ci 988 has been researched along with cholecystokinin (26-33) in 1 studies
| Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (cholecystokinin (26-33)) | Trials (cholecystokinin (26-33)) | Recent Studies (post-2010) (cholecystokinin (26-33)) |
|---|---|---|---|---|---|
| 147 | 8 | 14 | 31 | 0 | 2 |
| Protein | Taxonomy | ci 988 (IC50) | cholecystokinin (26-33) (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.0282 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.0269 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horwell, DC | 1 |
1 other study(ies) available for ci 988 and cholecystokinin (26-33)
| Article | Year |
|---|---|
Development of CCK-B antagonists.
Topics: Amino Acid Sequence; Animals; Binding Sites; Blood-Brain Barrier; Cerebral Cortex; Cholecystokinin; Drug Design; Indoles; Meglumine; Mice; Molecular Sequence Data; Peptide Fragments; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship | 1991 |